RB1 and central nervous system cancer: In contrast, additional mutations or copy number alterations (CNAs) leading to RB pathway and phosphatidylinositol-3-kinase (PI3K) -AKT pathway dysregulation were frequent in recurrent gliomas, especially in the G-CIMP-demethylated (C.3) tumors.